EP2709613
AÐFERÐIR TIL AÐ MEÐHÖNDLA HCV
Status:
EP einkaleyfi: Endurútgefin þýðing EP einkaleyfisEP appl. date:
14.9.2012EP published:
29.11.2017EP application number:
12768967.7
EP translation filed:
10.1.2018Grant published:
15.2.2018EPO information:
European Patent Register
Max expiry date:
13.9.2032Expiry date:
13.9.2026Next due date:
30.9.2026
Title:
METHODS FOR TREATING HCV
Timeline
Today
14.9.2012EP application
29.11.2017EP Publication
10.1.2018Translation submitted
15.2.2018Registration published
13.9.2026Expires
Owner
Name:
Gilead Pharmasset LLCAddress:
c/o Gilead Sciences, Inc. 333 Lakeside Drive, 94404, Foster City, CA, US
Inventor
Name:
RAY, Adrian S.Address:
Foster City, CA, US
Name:
WATKINS, William J.Address:
Foster City, CA, US
Name:
LINK, John O.Address:
Foster City, CA, US
Name:
OLDACH, David W.Address:
Chapel Hill, North Carolina, US
Name:
DELANEY, IV, William E.Address:
Foster City, California, US
Agent
Name:
G.H. Sigurgeirsson ehf.Address:
Borgartúni 26, 105, Reykjavík,
Priority
Number:
201161535885 PDate:
16.9.2011Country:
US
Number:
201161561753 PDate:
18.11.2011Country:
US
Classification
Categories:
A61K 31/381, A61K 31/4184, A61K 31/4196, A61K 31/513, A61P 31/14
Annual fees
Number
Paid
Expires
Payer
Number: 7
Paid: 20.8.2018
Expires: 13.9.2019
Payer: Sigurjónsson & Thor ehf.
Number: 8
Paid: 20.8.2019
Expires: 13.9.2020
Payer: Sigurjónsson & Thor ehf.
Number: 9
Paid: 6.8.2020
Expires: 13.9.2021
Payer: Árnason Faktor ehf.
Number: 10
Paid: 10.8.2021
Expires: 13.9.2022
Payer: Árnason Faktor ehf.
Number: 11
Paid: 16.8.2022
Expires: 13.9.2023
Payer: Árnason Faktor ehf.
Number: 12
Paid: 5.9.2023
Expires: 13.9.2024
Payer: Árnason Faktor ehf.
Number: 13
Paid: 7.8.2024
Expires: 13.9.2025
Payer: Árnason Faktor ehf.
Number: 14
Paid: 10.9.2025
Expires: 13.9.2026
Payer: Árnason Faktor ehf.